Compression plagiarism: An “under-recognized variety” that software will miss

Michael Dougherty

If you’re interested in plagiarism in the scholarly literature nowadays, you’ve probably come across the name Michael Dougherty. Dougherty’s efforts to root out plagiarism has led to dozens of retractions, including several by a prominent priest. In a new paper in Argumentation, Dougherty, author of the recent book Correcting the Scholarly Record for Research Integrity: In the Aftermath of Plagiarism, has coined a new term: “compression plagiarism.” We asked him more about the phenomenon, which Dougherty says “is invisible to unsuspecting readers and immune to anti-plagiarism software.”

Retraction Watch (RW): You define a term that is new to us: Compression plagiarism. What is compression plagiarism, and why is it particularly problematic? Continue reading Compression plagiarism: An “under-recognized variety” that software will miss

Journalist’s questions lead to expression of concern for paper on melatonin and pistachios

Nicola Kuhrt

A spectroscopy journal has issued an expression of concern over a 2014 paper by researchers in Iran on the amount of the sleep hormone melatonin in pistachios after German authorities — prompted by a journalist’s questions — concluded that the analysis was in error.

The article, “Expression of concern to spectrofluorimetric determination of melatonin in kernels of four different pistacia varieties after ultrasound-assisted solid-liquid extraction,” was published in Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy, an Elsevier journal.

The authors, from the University of Kerman, reported: Continue reading Journalist’s questions lead to expression of concern for paper on melatonin and pistachios

Should a paper on mindfulness have been retracted? A co-author weighs in

Myriam Hunink

Two weeks ago, we covered the retraction of a PLoS ONE paper on mindfulness following criticism — dating back to 2017 — by James Coyne. At the time, the corresponding author, Maria Hunink, of Erasmus and Harvard, had not responded to a request for comment. Hunink responded late last week, saying that she had been on vacation, and with her permission we are posting her comments — including a correction she and her co-authors had originally drafted –here in the spirit of what she called “a fair and open discussion on Retraction Watch.” 

We sent an email to PLoS ONE in response to their intention to retract our paper explaining why we disagree with retraction but it seems they did not change their statement and went ahead with retraction. We suggested that discussing the methodological issues is a more rational approach and beneficial than retraction but received no response.

In spite of its methodological limitations, we feel the paper is a valuable contribution. Continue reading Should a paper on mindfulness have been retracted? A co-author weighs in

Weekend reads: A U.S. gov’t memo on publishing leaves scientists in disbelief; money wasted on flawed research; an eye doctor whose research subjects were at risk

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured the retraction of a paper on red wine, tea, and cancer; a look at why researchers make up co-authors’ names, and how PLOS ONE has become a “major retraction engine.” Here’s what was happening elsewhere: Continue reading Weekend reads: A U.S. gov’t memo on publishing leaves scientists in disbelief; money wasted on flawed research; an eye doctor whose research subjects were at risk

Do wind turbines cause plagiarism? Energy researcher up to 20 retractions

By Narcisa Aciko

The editors of PLoS ONE have done something that we’re betting Donald Trump will never do: Retract a statement about noisy wind turbines.

The journal is pulling a 2014 article, titled “Adaptive neuro-fuzzy methodology for noise assessment of wind turbine,” after concluding that the researchers plagiarized. The corresponding author of the article is Shahaboddin Shamshirban, of the Department of Computer System and Information Technology at the University of Malaya in Kuala Lumpur, Malaysia, and the retraction isn’t his first. In fact, it’s not even the only one Shamshirban has in PLoS ONE this week. The journal also is retracting a 2016 paper from his group, bringing his total to 20, for sins including plagiarism and faked peer review.

According to the retraction notice for the turbine study, which has been cited 23 times, according to Clarivate Analytics’ Web of Science: Continue reading Do wind turbines cause plagiarism? Energy researcher up to 20 retractions

How one journal became a “major retraction engine”

If you think you’ve noticed more and more retractions at PLoS ONE recently, you’re not wrong.

The journal retracted 53 papers last year. That’s not a record — that belongs to a journal that retracted more than 400 papers at once — nor is it that many more than the Journal of Biological Chemistry, which retracted 39 last year. And it’s only about 3% of the year’s retractions. But it’s a dramatic increase, as this graphic shows: Continue reading How one journal became a “major retraction engine”

“A new form of plagiarism:” When researchers fake co-authors’ names

Mario Biagioli

There’s a new publishing trend in town, says Mario Biagioli: Faking co-authors’ names. Biagioli, distinguished professor of law and science and technology studies and director of the Center for Innovation Studies at the University of California, Davis, writes in an article in Trends in Chemistry that it’s “the emergence of a new form of plagiarism that reflects the new metrics-based economy of scholarly publishing.” We asked him a few questions about what he’s found, and why authors might do this.

Retraction Watch (RW): You write that “A new trend in scientific misconduct involves listing fake coauthors on one’s publication.” Why would authors do that? Continue reading “A new form of plagiarism:” When researchers fake co-authors’ names

Maybe combining red wine and tea doesn’t kill tumors after all

According to the internet, Bear Grylls, the TV survivalist, said he “was always brought up to have a cup of tea at halfway up a rock face.” Which sounds too cute to be true and, given Grylls’ history of, um, buffing the hard edges of reality, almost certainly isn’t.

But Grylls appears to be far from alone in his tea hyperbole. A group of researchers in India has lost their 2011 paper in PLoS ONE on the synergistic effects of black tea and resveratrol — the compound in red wine touted as a fountain of youth —  on skin cancer for what (if we’re allowed to read the tea leaves) amounts to a cuppa apparent data fabrication.

Weak tea, indeed. And in mice, we should note, in a nod to “data thug” James Heathers’ most recent venture. Continue reading Maybe combining red wine and tea doesn’t kill tumors after all

Weekend reads: Ousted at MD Anderson; an “under-recognized variety of plagiarism;” a data thug rolls again

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured revelations about a Harvard lab being investigated by federal officials; a researcher who blamed a dead colleague for plagiarism; and the retraction of a paper on mindfulness. Here’s what was happening elsewhere: Continue reading Weekend reads: Ousted at MD Anderson; an “under-recognized variety of plagiarism;” a data thug rolls again

Harvard cancer lab subject to federal misconduct probe

Sam W. Lee, a Harvard researcher — or perhaps former Harvard researcher — who has lost three papers to retraction, including one from Nature, now has an expression of concern for another article, this one in Molecular and Cellular Biology.

The notice for that paper, 2000’s “Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression,” reads: Continue reading Harvard cancer lab subject to federal misconduct probe